Phase I study of the safety and pharmacokinetics of trabectedin with docetaxel in patients with advanced malignancies-Reference-Cited by-同舟云学术

Phase I study of the safety and pharmacokinetics of trabectedin with docetaxel in patients with advanced malignancies

Published:2015-03-20 Issue:5 Volume:75 Page:1047-1055
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

von Mehren Margaret,Bookman Michael,Meropol Neal J.,Weiner Louis M.,Sherman Eric,Li Jinhui,Knoblauch Roland,Parekh Trilok,Cohen Roger B.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-015-2705-z.pdf

Reference43 articles.

1. European Medicines Agency. Yondelis: Product Information. http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000773/human_med_001165.jsp&murl=menus/medicines/medicines.jsp&jsenabled=true . Accessed 15 Oct 2014

2. Zewail-Foote M, Hurley LH (1999) Ecteinascidin 743: a minor groove alkylator that bends DNA toward the major groove. J Med Chem 42:2493–2497. doi: 10.1021/jm990241l

3. Minuzzo M, Marchini S, Broggini M et al (2000) Interference of transcriptional activation by the antineoplastic drug ecteinascidin-743. Proc Natl Acad Sci USA 97:6780–6784. doi: 10.1073/pnas.97.12.6780

4. Takebayashi Y, Pourquier P, Zimonjic DB et al (2001) Antiproliferative activity of ecteinascidin 743 is dependent upon transcription-coupled nucleotide-excision repair. Nat Med 7:961–966. doi: 10.1038/91008

5. Martinez EJ, Corey EJ, Owa T (2001) Antitumor activity- and gene expression-based profiling of ecteinascidin Et 743 and phthalascidin Pt 650. Chem Biol 8:1151–1160. doi: 10.1016/S1074-5521(01)00082-5

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trabectedin for the therapy of ovarian cancer;Drugs of Today;2020

2. Starvation tactics using natural compounds for advanced cancers: pharmacodynamics, clinical efficacy, and predictive biomarkers;Cancer Medicine;2018-05-06

3. The efficacy of trabectedin in treating ovarian cancer;Expert Opinion on Pharmacotherapy;2017-02-06

4. Efficacy of trabectedin for the treatment of liposarcoma;Expert Opinion on Pharmacotherapy;2016-09-15

5. Trabectedin for the treatment of breast cancer;Expert Opinion on Investigational Drugs;2015-12-22